TY - JOUR
T1 - Prior antimicrobial agent use increases the risk of sporadic infections with multidrug-resistant Salmonella enterica serotype typhimurium
T2 - A foodnet case-control study, 1996-1997
AU - Glynn, M. Kathleen
AU - Reddy, Vasudha
AU - Hutwagner, Lori
AU - Rabatsky-Ehr, Therese
AU - Shiferaw, Beletshachew
AU - Vugia, Duc J.
AU - Segler, Suzanne
AU - Bender, Jeff
AU - Barrett, Timothy J.
AU - Angulo, Frederick J.
AU - Glynn, Kathleen
N1 - Funding Information:
Financial support: Centers for Disease Control and Prevention, National Center for Infectious Diseases; US Department of Agriculture, Food Safety and Inspection Service; and US Food and Drug Administration, Center for Food Safety and Applied Nutrition.
PY - 2004/4/15
Y1 - 2004/4/15
N2 - Several strains of multidrug-resistant (MDR) Salmonella serotype Typhimurium, including MDR S. Typhimurium definitive type 104, cause almost 10% of Salmonella infections among humans in the United States. To determine the risk factors for acquiring sporadic MDR S. Typhimurium infection, we conducted a population-based, case-control study using data from the Foodborne Diseases Active Surveillance Network (FoodNet) during 1996-1997. S. Typhimurium isolates from 5 FoodNet surveillance areas (California, Connecticut, Georgia, Minnesota, and Oregon) were tested for antimicrobial resistance and phage typing. Telephone interviews were conducted with ill persons and matched control subjects. Compared with both control subjects and patients infected with pansensitive strains of S. Typhimurium, patients with MDR S. Typhimurium infection were significantly more likely to have received an antimicrobial agent, particularly an agent to which the Salmonella isolate was resistant, during the 4 weeks preceding illness onset. Prudent antimicrobial agent use among humans and among veterinarians and food-animal producers is necessary to reduce the burden of drug-resistant salmonellosis in humans.
AB - Several strains of multidrug-resistant (MDR) Salmonella serotype Typhimurium, including MDR S. Typhimurium definitive type 104, cause almost 10% of Salmonella infections among humans in the United States. To determine the risk factors for acquiring sporadic MDR S. Typhimurium infection, we conducted a population-based, case-control study using data from the Foodborne Diseases Active Surveillance Network (FoodNet) during 1996-1997. S. Typhimurium isolates from 5 FoodNet surveillance areas (California, Connecticut, Georgia, Minnesota, and Oregon) were tested for antimicrobial resistance and phage typing. Telephone interviews were conducted with ill persons and matched control subjects. Compared with both control subjects and patients infected with pansensitive strains of S. Typhimurium, patients with MDR S. Typhimurium infection were significantly more likely to have received an antimicrobial agent, particularly an agent to which the Salmonella isolate was resistant, during the 4 weeks preceding illness onset. Prudent antimicrobial agent use among humans and among veterinarians and food-animal producers is necessary to reduce the burden of drug-resistant salmonellosis in humans.
UR - http://www.scopus.com/inward/record.url?scp=11144355851&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=11144355851&partnerID=8YFLogxK
U2 - 10.1086/381591
DO - 10.1086/381591
M3 - Review article
C2 - 15095194
AN - SCOPUS:11144355851
SN - 1058-4838
VL - 38
SP - S227-S236
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - SUPPL. 3
ER -